Description

Product Description:

This compound is a synthetic glucagon-like peptide-1 (GLP-1) receptor agonist, designed to interact with incretin receptors involved in metabolic and endocrine signaling pathways. It has been widely studied in research settings for its role in hormonal regulation and receptor-mediated biological processes.

In experimental models, GLP-1 receptor agonists are utilized to examine glucose metabolism, peptide-receptor interactions, and downstream signaling mechanisms. Structural modifications within this class of compounds allow for extended receptor activity, making them valuable tools in studies focused on sustained pathway engagement.

This material is commonly applied in in vitro and laboratory-based research models investigating metabolic signaling, endocrine system function, and peptide activity.

Key Features:

Compound Type: GLP-1 receptor agonist
Molecular Formula: Proprietary peptide structure
CAS Number: Not disclosed / research reference compound
Structure: Modified GLP-1 analog
Physical Form: Lyophilized powder
Compound Class: Synthetic peptide / incretin mimetic
Purity: ≥98% (HPLC)
Storage Conditions: Store at 36–46°F (2–8°C) in a dry, light-protected environment.

Research References:

• Lau, J. et al. (2015). Development of long-acting GLP-1 analogs for metabolic research. Journal of Medicinal Chemistry.
• Kapitza, C. et al. (2015). Pharmacodynamic properties of GLP-1 receptor agonists in research settings. Diabetes, Obesity and Metabolism.
• Drucker, D. J. (2018). Mechanisms of action of GLP-1 receptor agonists. Cell Metabolism.

(References provided for informational and research context only.)

Important Notice:

This product is intended for research use only. It is not for human or veterinary use. It is not intended to diagnose, treat, cure, or prevent any disease. Use is restricted to qualified professionals in controlled laboratory environments.